Institutional Fund
Parkman Healthcare Partners LLC
Stamford, CTCIK 17770155 filings on record
Portfolio Value
$964.56M
Q1 2026
Holdings
89
Reported positions
New Buys
17
Opened this quarter
QoQ Change
-8.2%
from $1.05B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Stryker Corporation5.3%
- Dexcom Inc4.5%
- Kalvista Pharmaceuticals Inc3.8%
- Insulet Corp3.4%
- Eli Lilly & Co3.3%
- Ptc Therapeutics Inc3.0%
- Other76.7%
Portfolio Holdings
89 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Stryker Corporation | 154.8K | $50.86M | 5.3% | +49.3K | Added |
| 2 | Dexcom Inc | 689.8K | $43.32M | 4.5% | +102.3K | Added |
| 3 | Kalvista Pharmaceuticals Inc | 1.84M | $36.95M | 3.8% | +67.0K | Added |
| 4 | Insulet Corp | 156.6K | $32.85M | 3.4% | +15.7K | Added |
| 5 | Eli Lilly & Co | 34.6K | $31.84M | 3.3% | +34.6K | New |
| 6 | Ptc Therapeutics Inc | 431.4K | $29.39M | 3.0% | +271.2K | Added |
| 7 | Xenon Pharmaceuticals Inc | 497.0K | $28.90M | 3.0% | +342.9K | Added |
| 8 | Boston Scientific Corp | 448.8K | $28.16M | 2.9% | −51.8K | Reduced |
| 9 | Cvs Health Corp | 387.3K | $27.82M | 2.9% | −62.9K | Reduced |
| 10 | Arcus Biosciences Inc | 1.21M | $26.08M | 2.7% | +238.7K | Added |
79 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio